Jie Zhou

This inventor holds 9 USPTO granted patents and 5 published patent applications, plus 4 CIPO patents and 3 EPO patents. Top assignees: Atyr Pharma, Inc., Pangu Biopharma Limited, Paneu Biopharma Limited. Active years: 2013-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jie Zhou. Retrieved from https://idiyas.com/inventor/jie-zhou-iya70ze0

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 9 (Patent Applications = 5)

% Patents Active = 100.0

CIPO Patents = 4 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 5.7

ph-index = 4

Forward Citations = 124(Granted Patents)

Company Filing History:

Pangu Biopharma Limited

patents

1 out of 1

Paneu Biopharma Limited

where one patent can have more than one assignee

Years Active: 2013-2025

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12497466 - COMPOSITIONS AND METHODS COMPRISING HISTIDYL-TRNA SYNTHETASE SPLICE VARIANTS HAVING NON-CANONICAL BIOLOGICAL ACTIVITIES (2025-12-16),

2. 11078299 - Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities (2021-08-03),

3. 10941214 - Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities (2021-03-09),

4. 10792275 - Inhibiting binding of influenza-virus PB2 subunit to RNA cap (2020-10-06),

5. 10526419 - Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities (2020-01-07),

6. 10017582 - Compositions and methods comprising histidyl-trna synthetase splice variants having non-canonical biological activities (2018-07-10),

7. 9605265 - Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities (2017-03-28),

8. 8753638 - Compositions and methods comprising histidyl-TRNA synthetase splice variants having non-canonical biological activities (2014-06-17),

9. 8404242 - Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities (2013-03-26),

Title: Inventor Jie Zhou - Revolutionizing Technology in Hong Kong

Introduction: Jie Zhou is a visionary inventor based in Hong Kong, China, known for his groundbreaking contributions to the field of technology.

Latest Patents: Jie Zhou holds several patents in the areas of artificial intelligence, robotics, and renewable energy technologies, showcasing his innovative mindset and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Jie Zhou has worked with leading tech companies and research institutions, spearheading projects that have pushed the boundaries of technological advancements.

Collaborations: Throughout his career, Jie Zhou has collaborated with top engineers, scientists, and researchers globally, fostering a culture of innovation and knowledge sharing in the tech industry.

Conclusion: Jie Zhou's relentless pursuit of innovation and his passion for creating technology that makes a difference have solidified his position as a prominent figure in the world of inventors and innovators.

Profile summary based on public USPTO records.